Chugai Pharmaceutical Co (TSE:4519) Other Operating Expense : 円-2,701 Mil (TTM As of Mar. 2025)

View and export this data going back to 1956. Start your Free Trial

What is Chugai Pharmaceutical Co Other Operating Expense?

Chugai Pharmaceutical Co's Other Operating Expense for the three months ended in Mar. 2025 was 円-178 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was 円-2,701 Mil.

Chugai Pharmaceutical Co's quarterly Other Operating Expense increased from Sep. 2024 (円-1,645 Mil) to Dec. 2024 (円-275 Mil) and increased from Dec. 2024 (円-275 Mil) to Mar. 2025 (円-178 Mil).

Chugai Pharmaceutical Co's annual Other Operating Expense declined from Dec. 2022 (円64 Mil) to Dec. 2023 (円-28,561 Mil) but then increased from Dec. 2023 (円-28,561 Mil) to Dec. 2024 (円-2,339 Mil).

Chugai Pharmaceutical Co Other Operating Expense Historical Data

The historical data trend for Chugai Pharmaceutical Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chugai Pharmaceutical Co Other Operating Expense Chart

Chugai Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Operating Expense

Get a 7-Day Free Trial

64.00

-28,561.00

-2,339.00

Chugai Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Operating Expense	Get a 7-Day Free Trial															185.00	-603.00	-1,645.00	-275.00	-178.00

Chugai Pharmaceutical Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-2,701 Mil.

Chugai Pharmaceutical Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Chugai Pharmaceutical Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Chugai Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chugai Pharmaceutical Co Ltd (TSE:4519) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

CHGCY:USA CHGCF:USA 4519N:Mexico CUP:Germany

Address

1-1 Nihonbashi-Muromachi 2-Chome, Nihonbashi Mitsui Tower (Reception15F), Chuo-ku, Tokyo, JPN, 103-8324

Website

http://www.chugai-pharm.co.jp

Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly half of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines. It is an industry leader in antibody technology with several flagship therapies, including Hemlibra for hemophilia A patients and Actemra for treating rheumatoid arthritis and covid patients.

Chugai Pharmaceutical Co Headlines

No Headlines